Read More Healthcare Industry News Immuron (ASX: IMC) takes PROIBS to US as Nasdaq ADR jumps 62% Immuron Limited has signed an exclusive U.S. distribution agreement with Sweden’s Calmino group AB for PROIBS, extending its digestive-health portfolio beyond Travelan after reporting record FY26 sales of A$7.7 million. bySrinathSeptember 6, 2026